Zejula Approved for Certain Female Cancers

TUESDAY, March 28, 2017 — Zejula (niraparib) has been approved by the U.S. Food and Drug Administration to treat adult women with recurring cancers of the ovaries, fallopian tubes or abdominal wall (peritoneum) whose tumors have shrunk in response…
Source: Topamax